(Q57691928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371611%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

editorial

0 references

title

Active vitamin D compounds and analogues: a new therapeutic era for dermatology in the 21st century (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371611%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

0 references

0 references

1

Michael F. Holick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371611%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

language of work or name

English

0 references

publication date

1 September 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371611%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371611%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371611%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371611%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

925-927

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371611%20AND%20SRC:MED&resulttype=core&format=json

Treatment of postmenopausal osteoporosis with calcitriol or calcium

30 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960704-6

Regulation of Terminal Differentiation of Cultured Mouse Epidermal Cells by lα,25-Dihydroxyvitamin D3*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960704-6

Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960704-6

Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960704-6

A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960704-6

Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960704-6

In vitro metabolism of calcipotriol (MC 903), a vitamin D analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960704-6

Calcipotriol and hypercalcaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960704-6

Topical calcipotriol treatment in advanced breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960704-6

Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960704-6

10.1016/S0025-6196(12)60704-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371611%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference